JPMorgan downgraded Corteva (CTVA) to Neutral from Overweight with a price target of $77, up from $75. The firm cites valuation for the downgrade. Corteva plans to split into a seed company and a crop chemical company in the second half of 2026, most likely in Q4, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA: